To detect the presence of inflammation caused by one or more conditions such as infections, tumors or autoimmune diseases.
To screen for, help diagnose and/or monitor several diseases and conditions, such as kidney disorders or urinary tract infections (UTIs)
|Prostate Specific Antigen (PSA)|
To screen men for prostate cancer, to help determine the necessity for a biopsy of the prostate, to monitor the effectiveness of treatment for prostate cancer.
|Carcinoembryonic Antigen (CEA)|
This test is used primarily to monitor cancer treatment, including response to therapy and recurrence; as an indicator of the amount of cancer or size of tumor present (tumor burden) and to assist in cancer staging.
|Cancer Antigen 19-9|
This test is used primarily to monitor response to pancreatic cancer treatment and to watch for recurrence; sometimes to aid in the diagnosis of pancreatic cancer.
|Cancer Antigen 15-3|
Cancer antigen 15-3 (CA 15-3) is a protein that is produced by normal breast cells. In many people with cancerous breast tumors, there is an increased production of CA 15-3 and the related cancer antigen 27.29.
|Comprehensive Metabolic Panel (CMP)|
The comprehensive metabolic panel (CMP) is used as a broad screening tool to evaluate organ function and check for conditions such as diabetes, liver disease, and kidney disease. Includes 14 tests.
|CBC w / Differential|
The complete blood count (CBC) is often used as a broad screening test to determine an individual’s general health status including cardiac risk.
|CRP High Sensitivity|
The high-sensitivity CRP test measures low levels of CRP in the blood to identify low levels of inflammation that are associated with risk of developing cardiovascular disease (CVD).